Validation of the Chinese Western Ontario and McMaster Universities Osteoarthritis Index in Patients From Mainland China With Osteoarthritis of the Knee

Objective To establish the reliability, validity, and sensitivity to change of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) among Chinese subjects with osteoarthritis (OA) of the knee, living in mainland China. Methods A multicenter, randomized, double‐blind, placebo‐co...

Full description

Saved in:
Bibliographic Details
Published inArthritis care & research (2010) Vol. 67; no. 11; pp. 1553 - 1560
Main Authors Symonds, Tara, Hughes, Bernadette, Liao, Shanmei, Ang, Qiuqing, Bellamy, Nicholas
Format Journal Article
LanguageEnglish
Published United States 01.11.2015
Subjects
Online AccessGet full text
ISSN2151-464X
2151-4658
DOI10.1002/acr.22631

Cover

More Information
Summary:Objective To establish the reliability, validity, and sensitivity to change of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) among Chinese subjects with osteoarthritis (OA) of the knee, living in mainland China. Methods A multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study was conducted for validation of the electronic personal digital assistant version of the WOMAC Numerical Rating Scale (NRS) 3.1 Index in China. A total of 287 subjects with OA of the knee were randomized to receive either meloxicam (15 mg) or placebo. Psychometric properties of the WOMAC were evaluated by estimating the reliability, validity, and sensitivity to change. Equivalence of the electronic version was also compared with the paper version. Results Intraclass correlation coefficients for the WOMAC pain, stiffness, and physical function subscales were 0.81, 0.76, and 0.85, respectively, indicating good test–retest reliability. Similarly, internal consistency was strong (Cronbach's alpha for the 3 WOMAC subscales was 0.84, 0.86, and 0.96, respectively). Pearson's correlation coefficients for WOMAC pain and Short Form 36 health survey (SF‐36) bodily pain, as well as WOMAC physical function and SF‐36 physical functioning domains were >0.4, indicating convergent validity, whereas the coefficients for all 3 WOMAC domains with SF‐36 mental health and mental health component scores were <0.4, indicating divergent validity. There was strong discriminant validity between healthy volunteers and OA patients. The effect sizes of change from baseline to week 12 in WOMAC subscale scores were large, demonstrating sensitivity to change. Equivalence between paper and electronic versions was very high. Conclusion The culturally and linguistically validated Chinese version of the WOMAC NRS 3.1 for mainland China is psychometrically robust in its validity, reliability, and sensitivity to change for patients with OA of the knee.
Bibliography:Dr. Symonds owns stock or stock options from Pfizer. Dr. Hughes owns stock or stock options from Pfizer. Dr. Shanmei owns stock or stock options from Pfizer. Dr. Ang owns stock or stock options from Pfizer. Dr. Bellamy is the registered copyright holder and registered trademark holder for the WOMAC Index and receives licensing fees for the WOMAC Index, AUSCAN Index, and associated user guides.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:2151-464X
2151-4658
DOI:10.1002/acr.22631